A study from Ashkenazi and colleagues, using the HD-N171-82Q mice (expressing the first 171 amino acids of human HTT) and primary fibroblasts from HD patients, showed that mHTT outcompetes ataxin 3 in binding Beclin 1, avoiding its activation [288]. The gene discussed is HTT; the disease is Huntington disease.